Gynecologic Oncology Consult

Same-day discharge for hysterectomy


 

Preoperative strategies

Medication regimens for same-day discharge
Postoperative pain and nausea can be preempted with immediate preoperative doses of dexamethasone, gabapentin, ondansetron, celecoxib, and acetaminophen. Postoperative nausea is associated with dehydration; therefore, ensure patients are well hydrated preoperatively by avoiding bowel preparations and minimizing the duration of nothing-by-mouth status. Multimodal pain strategies have consistently shown improved perioperative pain control and decreased GI dysfunction.4

Intraoperative strategies

Consider in-and-out catheterization rather than placement of an indwelling catheter for anticipated short cases without complex bladder dissection.5 Minimize blood loss and maximally evacuate blood and clots with suction because hemoperitoneum can induce nausea and pain.

Pain from retained gas under the diaphragm can be reduced by bathing the diaphragms with 400 cc of dilute local anesthetic made by mixing 50 mL of 0.5% bupivacaine in 1000 mL normal saline prior to removal of pneumoperitoneum and while still in Trendelenburg. Ensure there is minimal retained intraperitoneal CO2 at the completion of the surgery by asking the anesthesiologists to perform positive pressure ventilations prior to fascial closure. Consider injecting port sites (including the peritoneal and fascial layers) with a mixture of immediate and long-acting local anesthetics. Request that the anesthesia staff administer intraoperative doses of IV ketorolac, acetaminophen, and tramadol (in preference to opioids) and an aggressive perioperative cocktail of antiemetics.

Pages

Recommended Reading

Approach to the asymptomatic adnexal mass: When to operate, refer, or observe
MDedge ObGyn
New multi-analyte blood test shows promise in screening for several common solid tumors
MDedge ObGyn
Letrozole promising as maintenance treatment for high-grade serous ovarian cancer
MDedge ObGyn
USPSTF: Routine screens for ovarian cancer not recommended
MDedge ObGyn
FDA approves new HPV assay
MDedge ObGyn
Telling her she has cancer: A patient-centered approach to breaking bad news
MDedge ObGyn
2018 Update on gynecologic cancer
MDedge ObGyn
Avelumab safety compares with other checkpoint inhibitors
MDedge ObGyn
FDA authorizes first direct-to-consumer BRCA1/2 test
MDedge ObGyn
Chlamydia infections associated with more than a doubling of ovarian cancer risk
MDedge ObGyn